1. Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
2. School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia;
3. PathWest Division of Clinical Pathology, Queen Elizabeth II Medical Centre, Nedlands, Australia;
4. Leukemia and Stem Cell Biology Group, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London, United Kingdom;
5. Sample Phenotype Ontology Team, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
6. Institute of Translation, Innovation, Methodology, and Engagement, Cardiff University School of Medicine, Cardiff, United Kingdom;
7. Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany;
8. German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany;
9. Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom;
10. Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and
11. Instituto de Biomedicina y Biotecnología de Cantabria, Santander, Spain